Please login to the form below

Not currently logged in


This page shows the latest Relvar news and features for those working in and with pharma, biotech and healthcare.

GSK's Breo fails to show survival benefit in COPD

GSK's Breo fails to show survival benefit in COPD

GlaxoSmithKline's struggling respiratory division has had more bad news, with new product Breo/Relvar failing to improve survival in a trial involving patients with chronic obstructive pulmonary disease (COPD).

Latest news

More from news
Approximately 2 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

‘Less Is More: Making Patient-Centered Digital Communication a Reality’
Letizia Affinito writes on the Gower Publishing blog....
The Seven Cs Of Cross-Functional Brand Planning
As more and more organisations have moved to cross-functional and cross-regional involvement in the development of their strategic and operational brand plans, the result has been greater engagement and alignment,...
2015/16 Pharmaceutical Titles
Browse our latest interactive Pharmaceutical and Healthcare catalogue...